Autologous T cells control B-chronic lymphocytic leukemia tumor progression in human→mouse radiation chimera

被引:0
|
作者
Shimoni, A
Marcus, H
Dekel, B
Shkarchi, R
Arditti, F
Shvidel, L
Shtalrid, M
Bucher, W
Canaan, A
Ergas, D
Berrebi, A
Reisner, Y [1 ]
机构
[1] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel
[2] Kaplan Hosp, Inst Hematol, IL-76100 Rehovot, Israel
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
B-chronic lymphocytic leukemia (B-CLL) is characterized by the clonal accumulation of CD5(+) B cells, It has been suggested that CLL cells may be regulated by inhibitory and growth-promoting signals exerted by autologous T cells. We have recently described a model for human B-CLL in which peripheral blood mononuclear cells (PBMCs) are transplanted into the peritoneal cavity of lethally irradiated mice radioprotected with bone marrow from mice with severe combined immunodeficiency, In this model, adoptive transfer of low-stage PBMCs leads to marked engraftment of T cells or combined T and CLL cell engraftment, whereas infusion of high-stage PBMCs leads to dominance of CLL cells with a miniscule level of T-cell engraftment. This mutual exclusive pattern of engraftment indicated that T. cells might control the expansion of tumor cells in the peritoneum of recipient BALB/c mice. In the present study, we further investigated this question and we demonstrate that is vivo T-cell depletion, using OKT3 antibody, markedly enhances the engraftment of B-CLL cells from patients with early-stage disease. In mice receiving PBMCs from 11 donors with advanced stage disease, the results were more heterogeneous, In five patients the results were similar to those observed in early stage, whereas in two cases no CLL cell engraftment was found in the absence of T cells. The addition of purified T cells to PBMCs led to a substantial decrease of CLL engraftment in three advanced-stage cases. These results strengthen the working hypothesis that autologous T cells can actively suppress the expansion of the pathological cells in human-->mouse radiation chimera. This effect is prominent in early-stage disease, whereas in advanced stage suppresive and/or stimulatory effects may occur in different patients, The interaction of T cells with tumor cells and the potential of autologous T cell/immune-therapy in CLL can be further explored in this model.
引用
收藏
页码:5968 / 5974
页数:7
相关论文
共 50 条
  • [21] PHENYLACETATE IS CYTOTOXIC TO B-CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) CELLS
    CALL, TG
    STENSON, MJ
    WITZIG, TE
    BLOOD, 1993, 82 (10) : A561 - A561
  • [22] Theophylline synergizes with chlorambucil in inducing apoptosis of B-chronic lymphocytic leukemia cells
    Mentz, F
    Mossalayi, MD
    Ouaaz, F
    Baudet, S
    Issaly, F
    Ktorza, S
    Semichon, M
    Binet, JL
    MerleBeral, H
    BLOOD, 1996, 88 (06) : 2172 - 2182
  • [23] EFFECTS OF PHENYLACETATE ON CELLS FROM PATIENTS WITH B-CHRONIC LYMPHOCYTIC-LEUKEMIA
    CALL, TG
    STENSON, MJ
    WITZIG, TE
    LEUKEMIA & LYMPHOMA, 1994, 14 (1-2) : 145 - 149
  • [24] T and B cells in B-chronic lymphocytic leukaemia: Faust, Mephistopheles and the pact with the Devil
    Mellstedt, H
    Choudhury, A
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2006, 55 (02) : 210 - 220
  • [25] T-CELL CD38 EXPRESSION IN B-CHRONIC LYMPHOCYTIC LEUKEMIA
    Abousamra, Nashwa K.
    El-Din, Manal Salah
    Azmy, Emad
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1490 - S1490
  • [26] UNUSUAL T-CELL PHENOTYPE IN ADVANCED B-CHRONIC LYMPHOCYTIC-LEUKEMIA
    MATUTES, E
    WECHSLER, A
    GOMEZ, R
    CHERCHI, M
    CATOVSKY, D
    BRITISH JOURNAL OF HAEMATOLOGY, 1981, 49 (04) : 635 - 642
  • [27] THE INFLUENCE OF T-CELLS FROM PATIENTS WITH B-CHRONIC LYMPHOCYTIC-LEUKEMIA ON INVITRO IGM SYNTHESIS
    WHELAN, CA
    MCCANN, SR
    BRITISH JOURNAL OF HAEMATOLOGY, 1982, 51 (02) : 325 - 325
  • [28] T and B cells in B-chronic lymphocytic leukaemia: Faust, Mephistopheles and the pact with the Devil
    Håkan Mellstedt
    Aniruddha Choudhury
    Cancer Immunology, Immunotherapy, 2006, 55 : 210 - 220
  • [29] Autologous stem cell transplantation (ASCT) as salvage treatment for advanced B-chronic lymphocytic leukemia (CLL).
    Sutton, L
    Maloum, K
    Cosset, JM
    Boccaccio, C
    Gonzalez, H
    Azar, N
    Leblond, V
    Binet, JL
    BONE MARROW TRANSPLANTATION, 1998, 21 : S77 - S77
  • [30] Cyclosporin A and dexamethasone induce apoptosis in malignant cells of patients with B-chronic lymphocytic leukemia
    Trentin, L.
    Cabrelle, A.
    Maschio, N.
    Carraro, S.
    Bonanni, L.
    Gattazzo, C.
    Biasiolo, G.
    Frezzato, F.
    Adami, F.
    Agostini, C.
    Miorin, M.
    Zambello, R.
    Pandolfi, F.
    Semenzato, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 487 - 487